Stroke Trial, Recruiting NCT05268861 Sponsor: McGill University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05268861
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had their first stroke (either a blockage or bleed in the brain) less than 3 years ago and whose condition is now medically stable.
  • People who are no longer receiving active treatment for their stroke.
  • People with normal vision, or vision that is fully corrected with glasses or contact lenses.
  • People who have some weakness and muscle stiffness in one arm after their stroke, but who can still move their elbow — bending and straightening it at least about 30 degrees in each direction.

Who may not be able to join:

  • People who have other significant neurological conditions or problems with their muscles or joints that could affect their ability to perform tasks in the trial.
  • People who have a significant loss of position sense in their elbow — meaning difficulty sensing where their arm is without looking at it — which could interfere with the trial tasks.
  • People who have a condition called visuospatial neglect, where the brain has difficulty paying attention to one side of space (measured using a standard line bisection test).
  • People whose vision problems are not corrected by glasses or contact lenses.
  • People who are experiencing significant depression, based on a standard questionnaire score (confirm with trial site for specific threshold details).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mindy Levin, PhD, PT, McGill University

Phone: (450) 688-9550

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
McGill University
Registry
ClinicalTrials.gov
Start date
1 April 2022
Est. completion
1 July 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in endpoint error; Change in movement time; Change in path straightness; Change in path smoothness; Change in range of active elbow extension; Change in size of active arm workspace area

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov